SPRO
Spero Therapeutics·NASDAQ
--
--(--)
--
--(--)
SPRO fundamentals
During Q4 2025, Spero Therapeutics (SPRO) reported revenue of 41.30M, a YoY change of 174.51%. Net income was 31.52M, a YoY change of 250.90%. Click to view the full income statement and explore the company's earnings performance.
Income Statement
Q3,2016 | Q4,2016 | Q1,2017 | Q2,2017 | Q3,2017 | Q4,2017 | Q1,2018 | Q2,2018 | Q3,2018 | Q4,2018 | Q1,2019 | Q2,2019 | Q3,2019 | Q4,2019 | Q1,2020 | Q2,2020 | Q3,2020 | Q4,2020 | Q1,2021 | Q2,2021 | Q3,2021 | Q4,2021 | Q1,2022 | Q2,2022 | Q3,2022 | Q4,2022 | Q1,2023 | Q2,2023 | Q3,2023 | Q4,2023 | Q1,2024 | Q2,2024 | Q3,2024 | Q4,2024 | Q1,2025 | Q2,2025 | Q3,2025 | Q4,2025 | TTM |
|---|
Start Date | Jul 1, 2016 | Oct 1, 2016 | Jan 1, 2017 | Apr 1, 2017 | Jul 1, 2017 | Oct 1, 2017 | Jan 1, 2018 | Apr 1, 2018 | Jul 1, 2018 | Oct 1, 2018 | Jan 1, 2019 | Apr 1, 2019 | Jul 1, 2019 | Oct 1, 2019 | Jan 1, 2020 | Apr 1, 2020 | Jul 1, 2020 | Oct 1, 2020 | Jan 1, 2021 | Apr 1, 2021 | Jul 1, 2021 | Oct 1, 2021 | Jan 1, 2022 | Apr 1, 2022 | Jul 1, 2022 | Oct 1, 2022 | Jan 1, 2023 | Apr 1, 2023 | Jul 1, 2023 | Oct 1, 2023 | Jan 1, 2024 | Apr 1, 2024 | Jul 1, 2024 | Oct 1, 2024 | Jan 1, 2025 | Apr 1, 2025 | Jul 1, 2025 | Oct 1, 2025 | -- |
End Date | Sep 30, 2016 | Dec 31, 2016 | Mar 31, 2017 | Jun 30, 2017 | Sep 30, 2017 | Dec 31, 2017 | Mar 31, 2018 | Jun 30, 2018 | Sep 30, 2018 | Dec 31, 2018 | Mar 31, 2019 | Jun 30, 2019 | Sep 30, 2019 | Dec 31, 2019 | Mar 31, 2020 | Jun 30, 2020 | Sep 30, 2020 | Dec 31, 2020 | Mar 31, 2021 | Jun 30, 2021 | Sep 30, 2021 | Dec 31, 2021 | Mar 31, 2022 | Jun 30, 2022 | Sep 30, 2022 | Dec 31, 2022 | Mar 31, 2023 | Jun 30, 2023 | Sep 30, 2023 | Dec 31, 2023 | Mar 31, 2024 | Jun 30, 2024 | Sep 30, 2024 | Dec 31, 2024 | Mar 31, 2025 | Jun 30, 2025 | Sep 30, 2025 | Dec 31, 2025 | -- |
Fiscal Year-End | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | -- |
Revenue | -- -- | 335.00K -- | 140.00K -- | 249.00K -- | 597.00K -- | 993.00K +196.42% | 1.15M +723.57% | 463.00K +85.94% | 658.00K +10.22% | 1.69M +70.39% | 7.72M +569.38% | 2.16M +365.66% | 4.64M +605.62% | 3.63M +114.54% | 1.70M -77.96% | 1.73M -19.90% | 4.00M -13.96% | 1.91M -47.47% | 7.30M +329.16% | 5.15M +198.09% | 3.06M -23.30% | 2.74M +43.89% | 2.07M -71.66% | 1.99M -61.29% | 2.01M -34.53% | 47.44M +1628.90% | 2.07M -- | 2.72M +36.28% | 25.47M +1169.84% | 73.52M +54.98% | 9.27M +347.90% | 10.20M +275.44% | 13.47M -47.12% | 15.04M -79.54% | 5.87M -36.61% | 14.19M +39.15% | 5.44M -59.60% | 41.30M +174.51% | 66.80M -- |
Sales and Services Revenue | -- -- | 335.00K -- | 140.00K -- | 249.00K -- | 597.00K -- | 993.00K +196.42% | 1.15M +723.57% | 463.00K +85.94% | 658.00K +10.22% | 1.69M +70.39% | 7.72M +569.38% | 2.16M +365.66% | 4.64M +605.62% | 3.63M +114.54% | 1.70M -77.96% | 1.73M -19.90% | 4.00M -13.96% | 1.91M -47.47% | 7.30M +329.16% | 5.15M +198.09% | 3.06M -23.30% | 2.74M +43.89% | 2.07M -71.66% | 1.99M -61.29% | 2.01M -34.53% | 47.44M +1628.90% | 2.07M -- | 2.72M +36.28% | 25.47M +1169.84% | 73.52M +54.98% | 9.27M +347.90% | 10.20M +275.44% | 13.47M -47.12% | 15.04M -79.54% | 5.87M -36.61% | 14.19M +39.15% | 5.44M -59.60% | 41.30M +174.51% | 66.80M -- |
Cost of Revenue | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Gross Profit | -- -- | 335.00K -- | 140.00K -- | 249.00K -- | 597.00K -- | 993.00K +196.42% | 1.15M +723.57% | 463.00K +85.94% | 658.00K +10.22% | 1.69M +70.39% | 7.72M +569.38% | 2.16M +365.66% | 4.64M +605.62% | -14.52M -957.98% | 1.70M -77.96% | 1.73M -19.90% | 4.00M -13.96% | -7.42M +48.87% | 7.30M +329.16% | 5.15M +198.09% | 3.06M -23.30% | -15.51M -108.97% | 2.07M -71.66% | 1.99M -61.29% | 2.01M -34.53% | -6.07M +60.88% | 2.07M -- | 2.72M +36.28% | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Operating Expenses | 7.91M -- | 9.14M -- | 7.74M -- | 10.41M -- | 10.56M +33.47% | 14.99M +63.95% | 11.97M +54.66% | 10.43M +0.19% | 11.59M +9.75% | 12.78M -14.79% | 13.41M +12.07% | 15.81M +51.50% | 22.63M +95.19% | 29.51M +131.00% | 24.52M +82.81% | 20.20M +27.80% | 23.02M +1.71% | 20.70M -29.85% | 26.70M +8.89% | 23.69M +17.26% | 25.59M +11.18% | 30.25M +46.09% | 32.28M +20.87% | 28.07M +18.50% | 13.84M -45.91% | 21.52M -28.86% | 16.30M -49.51% | 15.61M -44.41% | 27.41M +98.03% | 22.99M +6.85% | 23.25M +42.67% | 29.26M +87.48% | 32.06M +16.98% | 36.77M +59.93% | 20.61M -11.37% | 16.63M -43.15% | 13.36M -58.34% | 9.89M -73.10% | 60.49M -- |
Selling, General and Administrative Expenses | 1.91M -- | 2.22M -- | 1.74M -- | 2.96M -- | 3.65M +91.36% | 2.49M +12.26% | 3.04M +74.94% | 3.06M +3.48% | 3.13M -14.21% | 3.65M +46.55% | 3.89M +27.73% | 3.78M +23.59% | 4.13M +31.88% | 3.79M +3.73% | 4.09M +5.09% | 4.55M +20.23% | 5.31M +28.45% | 7.50M +98.10% | 8.30M +103.11% | 9.23M +102.97% | 11.15M +110.06% | 13.02M +73.66% | 15.30M +84.42% | 8.05M -12.76% | 6.63M -40.53% | 6.50M -50.12% | 7.32M -52.19% | 6.10M -24.28% | 5.71M -13.93% | 6.43M -0.95% | 5.92M -19.13% | 5.53M -9.24% | 5.20M -8.93% | 7.06M +9.68% | 6.82M +15.33% | 5.88M +6.24% | 4.17M -19.70% | 4.30M -39.06% | 21.18M -- |
General and Administrative Expenses | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 5.71M -- | -19.12M -- | 5.92M -- | 5.53M -- | 5.20M -8.93% | 7.06M +136.90% | 6.82M +15.33% | 5.88M +6.24% | 4.17M -19.70% | 4.30M -39.06% | 21.18M -- |
Research and Development Expenses | 6.00M -- | 6.93M -- | 6.00M -- | 7.46M -- | 6.91M +15.07% | 12.50M +80.50% | 8.93M +48.77% | 7.37M -1.11% | 8.46M +22.42% | 9.13M -27.00% | 9.53M +6.73% | 12.03M +63.09% | 18.50M +118.64% | 25.73M +181.89% | 20.44M +114.53% | 15.66M +30.18% | 17.71M -4.27% | 13.21M -48.67% | 18.40M -9.94% | 14.46M -7.63% | 14.44M -18.47% | 17.23M +30.44% | 16.97M -7.79% | 8.17M -43.48% | 7.36M -49.02% | 15.09M -12.40% | 8.98M -47.09% | 9.51M +16.36% | 16.39M +122.73% | 16.56M +9.73% | 17.33M +93.03% | 23.73M +149.47% | 26.86M +63.87% | 28.84M +74.16% | 13.61M -21.50% | 10.67M -55.02% | 8.60M -68.00% | 5.59M -80.61% | 38.47M -- |
Loss on Impairment of Other Assets | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | 5.31M -- | 0 -- | -- -- | -- -- | 0 -100.00% | 0 -- | -- -- | -- -- | 587.00K -- | 0 -- | -- -- |
Other Operating Expenses | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 0 -- | 0 -- | 0 -- | -- -- | 11.85M -- | -152.00K -- | -67.00K -- | -- -- | -- -- | -- -- | 0 +100.00% | 0 -- | 0 -- | 0 -- | 877.00K -- | 175.00K -- | 83.00K -- | 0 -- | 0 -100.00% | 258.00K -- |
Operating Income | -7.91M -- | -8.81M -- | -7.60M -- | -10.16M -- | -9.97M -25.93% | -14.00M -58.91% | -10.82M -42.33% | -9.97M +1.91% | -10.94M -9.72% | -11.08M +20.83% | -5.70M +47.34% | -13.65M -36.92% | -17.98M -64.47% | -25.88M -133.52% | -22.82M -300.65% | -18.48M -35.34% | -19.02M -5.75% | -18.80M +27.38% | -19.40M +14.98% | -18.54M -0.36% | -22.52M -18.42% | -27.50M -46.32% | -30.21M -55.68% | -26.08M -40.65% | -11.83M +47.46% | 25.92M +194.26% | -14.23M +52.90% | -12.89M +50.58% | -1.93M +83.66% | 50.53M +94.92% | -13.98M +1.72% | -19.06M -47.87% | -18.59M -861.38% | -21.73M -142.99% | -14.73M -5.36% | -2.44M +87.18% | -7.92M +57.42% | 31.41M +244.56% | 6.31M -- |
Non-Operating Income (Loss) | -4.00K -- | 613.00K -- | 1.19M -- | 402.00K -- | 122.00K +3150.00% | 132.00K -78.47% | 172.00K -85.52% | 15.00K -96.27% | 472.00K +286.89% | 485.00K +267.42% | 624.00K +262.79% | 502.00K +3246.67% | 268.00K -43.22% | 897.00K +84.95% | -437.00K -170.03% | 975.00K +94.22% | 84.00K -68.66% | 211.00K -76.48% | -20.00K +95.42% | -30.00K -103.08% | 3.00K -96.43% | -1.74M -923.70% | -2.62M -13010.00% | -2.60M -8573.33% | 159.00K +5200.00% | 847.00K +148.73% | 961.00K +136.65% | 976.00K +137.51% | 940.00K +491.19% | 1.05M +23.49% | 1.31M +36.63% | 1.20M +22.85% | 1.16M +22.98% | 1.13M +7.74% | 865.00K -34.12% | 744.00K -37.95% | 534.00K -53.81% | 376.00K -66.64% | 2.52M -- |
Gain (Loss) on Other Investment | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 223.00K -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Gain (Loss) on Change in Fair Value | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 204.00K -- | -- -- | -- -- | -- -- | 917.00K +349.51% | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Other Non-Operating Income (Loss) | -4.00K -- | 613.00K -- | 1.19M -- | 402.00K -- | 122.00K +3150.00% | 132.00K -78.47% | 172.00K -85.52% | 15.00K -96.27% | 472.00K +286.89% | -616.00K -566.67% | 385.00K +123.84% | 135.00K +800.00% | -135.00K -128.60% | 354.00K +157.47% | -674.00K -275.06% | 889.00K +558.52% | 55.00K +140.74% | 162.00K -54.24% | -118.00K +82.49% | -112.00K -112.60% | -87.00K -258.18% | -78.00K -148.15% | -206.00K -74.58% | -2.60M -2217.86% | -49.00K +43.68% | -785.00K -906.41% | -2.00K +99.03% | -6.00K +99.77% | -10.00K +79.59% | 3.00K +100.38% | -14.00K -600.00% | 1.00K +116.67% | -26.00K -160.00% | 99.00K +3200.00% | 1.00K +107.14% | 4.00K +300.00% | 2.00K +107.69% | 0 -100.00% | 7.00K -- |
Net Interest Expense | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -1.10M -- | -239.00K -- | -367.00K -- | -403.00K -- | -320.00K +70.94% | -237.00K +0.84% | -86.00K +76.57% | -29.00K +92.80% | -49.00K +84.69% | -98.00K +58.65% | -82.00K +4.65% | -90.00K -210.34% | 1.86M +3904.08% | 2.42M +2565.31% | 6.00K +107.32% | -208.00K -131.11% | -715.00K -138.36% | -963.00K -139.86% | -982.00K -16466.67% | -950.00K -356.73% | -1.04M -45.87% | -1.33M -37.80% | -1.20M -22.00% | -1.18M -24.42% | -1.03M +1.44% | -864.00K +34.89% | -740.00K +38.23% | -532.00K +54.99% | -376.00K +63.42% | -2.51M -- |
Interest Expense | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 1.94M -- | 2.49M -- | 117.00K -- | -- -- | 0 -100.00% | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Interest Income | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 1.10M -- | 239.00K -- | 367.00K -- | 403.00K -- | 320.00K -70.94% | 237.00K -0.84% | 86.00K -76.57% | 29.00K -92.80% | 49.00K -84.69% | 98.00K -58.65% | 82.00K -4.65% | 90.00K +210.34% | 76.00K +55.10% | 72.00K -26.53% | 111.00K +35.37% | 208.00K +131.11% | 715.00K +840.79% | 963.00K +1237.50% | 982.00K +784.68% | 950.00K +356.73% | 1.04M +45.87% | 1.33M +37.80% | 1.20M +22.00% | 1.18M +24.42% | 1.03M -1.44% | 864.00K -34.89% | 740.00K -38.23% | 532.00K -54.99% | 376.00K -63.42% | 2.51M -- |
Pretax Income From Continuing Operations | -7.92M -- | -8.20M -- | -6.41M -- | -9.76M -- | -9.84M -24.32% | -13.87M -69.18% | -10.64M -66.03% | -9.96M -1.98% | -10.46M -6.29% | -10.60M +23.57% | -5.07M +52.35% | -13.15M -32.08% | -17.72M -69.33% | -24.99M -135.74% | -23.26M -358.56% | -17.50M -33.09% | -18.94M -6.88% | -18.59M +25.62% | -19.42M +16.49% | -18.57M -6.12% | -22.52M -18.93% | -29.24M -57.33% | -32.83M -69.02% | -28.68M -54.44% | -11.68M +48.16% | 26.77M +191.56% | -13.27M +59.59% | -11.91M +58.46% | -994.00K +91.49% | 51.58M +92.66% | -12.67M +4.50% | -17.86M -49.92% | -17.44M -1654.23% | -20.60M -139.94% | -13.87M -9.45% | -1.70M +90.48% | -7.38M +57.66% | 31.78M +254.29% | 8.83M -- |
Income Tax Expense | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | 0 -- | 0 -- | -- -- | -- -- | 2.21M -- | 387.00K -- | -- -- | -- -- | -290.00K -113.12% | 290.00K -25.06% | -- -- | -- -- | 0 +100.00% | 261.00K -10.00% | -- -- |
Current Income Tax | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 2.60M -- | -- -- | -- -- | -- -- | 0 -100.00% | -- -- | -- -- | -- -- | 261.00K -- | -- -- |
Deferred Income Tax | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Net Income | -7.92M -- | -8.20M -- | -6.41M -- | -9.76M -- | -9.84M -24.32% | -13.87M -69.18% | -10.64M -66.03% | -9.96M -1.98% | -10.46M -6.29% | -10.60M +23.57% | -5.07M +52.35% | -13.15M -32.08% | -17.72M -69.33% | -24.99M -135.74% | -23.26M -358.56% | -17.50M -33.09% | -18.94M -6.88% | -18.59M +25.62% | -19.42M +16.49% | -18.57M -6.12% | -22.52M -18.93% | -29.24M -57.33% | -32.83M -69.02% | -28.68M -54.44% | -11.68M +48.16% | 26.77M +191.56% | -13.27M +59.59% | -11.91M +58.46% | -3.21M +72.55% | 51.19M +91.22% | -12.67M +4.50% | -17.86M -49.92% | -17.15M -435.01% | -20.89M -140.80% | -13.87M -9.45% | -1.70M +90.48% | -7.38M +56.95% | 31.52M +250.90% | 8.57M -- |
Net Income Attributable to Minority Interests | -1.60M -- | -986.00K -- | -535.00K -- | -594.00K -- | -8.00K +99.50% | -6.00K +99.39% | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Net Income Attributable to Owners of the Company | -6.32M -- | -7.21M -- | -5.88M -- | -9.17M -- | -9.84M -55.73% | -13.86M -92.23% | -10.64M -81.14% | -9.96M -8.58% | -10.46M -6.37% | -10.60M +23.54% | -5.07M +52.35% | -13.15M -32.08% | -17.72M -69.33% | -24.99M -135.74% | -23.26M -358.56% | -17.50M -33.09% | -18.94M -6.88% | -18.59M +25.62% | -19.42M +16.49% | -18.57M -6.12% | -22.52M -18.93% | -29.24M -57.33% | -32.83M -69.02% | -28.68M -54.44% | -11.68M +48.16% | 26.77M +191.56% | -13.27M +59.59% | -11.91M +58.46% | -3.21M +72.55% | 51.19M +91.22% | -12.67M +4.50% | -17.86M -49.92% | -17.15M -435.01% | -20.89M -140.80% | -13.87M -9.45% | -1.70M +90.48% | -7.38M +56.95% | 31.52M +250.90% | 8.57M -- |
Preferred Stock Dividends | 1.09M -- | 1.12M -- | 1.25M -- | 2.95M -- | 2.24M +104.75% | 908.00K -19.07% | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Net Income Attributable to Common Stockholders | -7.41M -- | -8.33M -- | -7.13M -- | -12.12M -- | -12.08M -62.97% | -14.77M -77.25% | -10.64M -49.28% | -9.96M +17.86% | -10.46M +13.36% | -10.60M +28.24% | -5.07M +52.35% | -13.15M -32.08% | -17.72M -69.33% | -24.99M -135.74% | -23.26M -358.56% | -17.50M -33.09% | -18.94M -6.88% | -18.59M +25.62% | -19.42M +16.49% | -18.57M -6.12% | -22.52M -18.93% | -29.24M -57.33% | -32.83M -69.02% | -28.68M -54.44% | -11.68M +48.16% | 26.77M +191.56% | -13.27M +59.59% | -11.91M +58.46% | -3.21M +72.55% | 51.19M +91.22% | -12.67M +4.50% | -17.86M -49.92% | -17.15M -435.01% | -20.89M -140.80% | -13.87M -9.45% | -1.70M +90.48% | -7.38M +56.95% | 31.52M +250.90% | 8.57M -- |
Other Comprehensive Income | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -29.00K -- | 14.00K -- | -8.00K -- | -5.00K -- | 29.00K +200.00% | 5.00K -64.29% | 12.00K +250.00% | -2.00K +60.00% | -35.00K -220.69% | 34.00K +580.00% | -14.00K -216.67% | -8.00K -300.00% | 4.00K +111.43% | 1.00K -97.06% | 0 +100.00% | 0 +100.00% | -4.00K -200.00% | 6.00K +500.00% | 0 -- | 0 -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Total Comprehensive Income | -7.92M -- | -8.20M -- | -6.41M -- | -9.76M -- | -9.84M -24.32% | -13.87M -69.18% | -10.67M -66.48% | -9.94M -1.83% | -10.47M -6.37% | -10.60M +23.54% | -5.04M +52.75% | -13.14M -32.22% | -17.70M -69.09% | -24.99M -135.65% | -23.29M -361.89% | -17.47M -32.88% | -18.95M -7.03% | -18.59M +25.59% | -19.42M +16.63% | -18.57M -6.32% | -22.52M -18.84% | -29.24M -57.26% | -32.83M -69.08% | -28.68M -54.41% | -11.68M +48.16% | 26.77M +191.56% | -13.27M +59.60% | -11.91M +58.45% | -3.21M +72.55% | 51.19M +91.22% | -12.67M +4.50% | -17.86M -49.92% | -17.15M -435.01% | -20.89M -140.80% | -13.87M -9.45% | -1.70M +90.48% | -7.38M +56.95% | 31.52M +250.90% | 8.57M -- |
Total Comprehensive Income Attributable to Owners of the Company | -7.92M -- | -8.20M -- | -6.41M -- | -9.76M -- | -9.84M -24.32% | -13.87M -69.18% | -10.67M -66.48% | -9.94M -1.83% | -10.47M -6.37% | -10.60M +23.54% | -5.04M +52.75% | -13.14M -32.22% | -17.70M -69.09% | -24.99M -135.65% | -23.29M -361.89% | -17.47M -32.88% | -18.95M -7.03% | -18.59M +25.59% | -19.42M +16.63% | -18.57M -6.32% | -22.52M -18.84% | -29.24M -57.26% | -32.83M -69.08% | -28.68M -54.41% | -11.68M +48.16% | 26.77M +191.56% | -13.27M +59.60% | -11.91M +58.45% | -3.21M +72.55% | 51.19M +91.22% | -12.67M +4.50% | -17.86M -49.92% | -17.15M -435.01% | -20.89M -140.80% | -13.87M -9.45% | -1.70M +90.48% | -7.38M +56.95% | 31.52M +250.90% | 8.57M -- |
Basic EPS | -23.23 -- | -- -- | -21.6 -- | -36.21 -- | -36.02 -55.06% | -1.03 -- | -0.74 +96.57% | -0.69 +98.09% | -0.6 +98.33% | -0.62 +39.81% | -0.29 +60.81% | -0.74 -7.25% | -0.95 -58.33% | -1.3 -109.68% | -1.22 -320.69% | -0.85 -14.86% | -0.86 +9.47% | -0.62 +52.31% | -0.66 +45.90% | -0.63 +25.88% | -0.7 +18.60% | -0.9 -45.16% | -1.01 -53.03% | -0.87 -38.10% | -0.33 +52.86% | 0.51 +156.67% | -0.25 +75.25% | -0.23 +73.56% | -0.06 +81.82% | 0.97 +90.20% | -0.24 +4.00% | -0.33 -43.48% | -0.32 -433.33% | -0.38 -139.18% | -0.25 -4.17% | -0.03 +90.91% | -0.13 +59.38% | 0.56 +247.37% | 0.15 -- |
Basic EPS from Continuing Operations | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -0.06 -- | -- -- | -0.24 -- | -0.33 -- | -0.32 -433.33% | -- -- | -0.25 -4.17% | -0.03 +90.91% | -0.13 +59.38% | -- -- | -- -- |
Diluted EPS | -23.23 -- | -- -- | -21.6 -- | -36.21 -- | -36.02 -55.06% | -- -- | -0.74 +96.57% | -0.69 +98.09% | -0.6 +98.33% | -- -- | -0.29 +60.81% | -0.74 -7.25% | -0.95 -58.33% | -- -- | -1.22 -320.69% | -0.85 -14.86% | -0.86 +9.47% | -- -- | -0.66 +45.90% | -0.63 +25.88% | -0.7 +18.60% | -- -- | -1.01 -53.03% | -0.87 -38.10% | -0.33 +52.86% | -- -- | -0.25 +75.25% | -0.23 +73.56% | -0.06 +81.82% | -- -- | -0.24 +4.00% | -0.33 -43.48% | -0.32 -433.33% | -- -- | -0.25 -4.17% | -0.03 +90.91% | -0.13 +59.38% | -- -- | -- -- |
Diluted EPS from Continuing Operations | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -0.06 -- | -- -- | -0.24 -- | -0.33 -- | -0.32 -433.33% | -- -- | -0.25 -4.17% | -0.03 +90.91% | -0.13 +59.38% | -- -- | -- -- |
You can ask Aime
Did Spero Therapeutics beat or miss consensus estimates last quarter?What is Spero Therapeutics's gross profit margin?What is Spero Therapeutics's latest dividend and current dividend yield?What were the key takeaways from Spero Therapeutics's earnings call?What is the revenue and EPS growth rate for Spero Therapeutics year over year?What factors drove the changes in Spero Therapeutics's revenue and profit?What guidance did Spero Therapeutics's management provide for the next earnings period?What were the key takeaways from Spero Therapeutics’s earnings call?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
